Pannexin 3 inhibits proliferation of osteoprogenitor cells by regulating Wnt and p21 signaling

Journal of Biological Chemistry

Volumn 289, Issue 5, 2014, Pages 2839-2851

  Ishikawa, Masaki ^a   Iwamoto, Tsutomu ^b   Fukumoto, Satoshi ^c   Yamada, Yoshihiko ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c TOHOKU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ATP; CALCIUM INTRACELLULAR RELEASE; CELL PROLIFERATION; HEMICHANNEL AND ER CA2+ CHANNEL; INTRACELLULAR ATP AND CA2+ LEVELS; P21; PANNEXIN; PANNEXIN 3; WNT SIGNALING; WNT/Β-CATENIN SIGNALING;

ANIMALS; ANIMALS, NEWBORN; BETA CATENIN; CALCIUM; CELL CYCLE CHECKPOINTS; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CONNEXINS; GLYCOGEN SYNTHASE KINASE 3; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; ORGAN CULTURE TECHNIQUES; OSTEOCYTES; P21-ACTIVATED KINASES; SKULL; STEM CELLS; WNT SIGNALING PATHWAY;

EID: 84893503166     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.523241     Document Type: Article

References (64)

1. Clevers, H., and Nusse, R. (2012) Wnt/β-catenin signaling and disease. Cell 149, 1192-1205
2. Moon, R. T., Bowerman, B., Boutros, M., and Perrimon, N. (2002) The promise and perils of Wnt signaling through β-catenin. Science 296, 1644-1646
3. Veeman, M. T., Axelrod, J. D., and Moon, R. T. (2003) A second canon. Functions and mechanisms of β-catenin-independent Wnt signaling. Dev. Cell 5, 367-377
4. Liu, C, Li, Y., Semenov, M., Han, C, Baeg, G. H., Tan, Y., Zhang, Z., Lin, X., and He, X. (2002) Control of β-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 108, 837-847
5. Li, V. S., Ng, S. S., Boersema, P. J., Low, T. Y., Karthaus, W. R., Gerlach, J. P., Mohammed, S., Heck, A. J., Maurice, M. M., Mahmoudi, T., and Clevers, H. (2012) Wnt signaling through inhibition ofβ-catenin degradation in an intact Axin1 complex. Cell 149, 1245-1256
6. Zeng, X., Tamai, K., Doble, B., Li, S., Huang, H., Habas, R., Okamura, H., Woodgett, J., and He, X. (2005) A dual-kinase mechanism for Wnt coreceptor phosphorylation and activation. Nature 438, 873-877
7. Bilic, J., Huang, Y.-L., Davidson, G., Zimmermann, T., Cruciat, C.-M., Bienz, M., and Niehrs, C. (2007) Wnt induces LRP6 signalosomes and promotes dishevelled-dependent LRP6 phosphorylation. Science 316, 1619-1622
8. Behrens, J., Von Kries, J. P., Kühl, M., Bruhn, L., Wedlich, D., Grosschedl, R., and Birchmeier, W. (1996) Functional interaction ofβ-catenin with the transcription factor LEF-1. Nature 382, 638-642
9. Huber, O., Korn, R., McLaughlin, J., Ohsugi, M., Herrmann, B. G., and Kemler, R. (1996) Nuclear localization of β-catenin by interaction with transcription factor LEF-1. Mech. Dev. 59, 3-10
10. Cross, D. A., Alessi, D. R., Cohen, P., Andjelkovich, M., and Hemmings, B. A. (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378, 785-789
11. Fang, X., Yu, S. X., Lu, Y., Bast, R. C, Jr., Woodgett, J. R., and Mills, G. B. (2000) Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A. Proc. Natl. Acad. Sci. U. S. A. 97, 11960-11965
12. Suzuki, A., Ozono, K., Kubota, T., Kondou, H, Tachikawa, K., and Michigami, T. (2008) PTH/cAMP/PKA signaling facilitates canonical Wnt signaling via inactivation of glycogen synthase kinase-3β in osteoblastic Saos-2 cells. J. Cell. Biochem. 104, 304-317
13. Hino, S., Tanji, C, Nakayama, K. I., and Kikuchi, A. (2005) Phosphorylation of β-catenin by cyclic AMP-dependent protein kinase stabilizes β-catenin through inhibition of its ubiquitination. Mol. Cell Biol. 25, 9063-9072
14. Gong, Y., Slee, R. B., Fukai, N., Rawadi, G., Roman-Roman, S., Reginato, A. M., Wang, H, Cundy, T., Glorieux, F. H, Lev, D., Zacharin, M., Oexle, K., Marcelino, J., Suwairi, W., Heeger, S., Sabatakos, G., Apte, S., Adkins, W. N., Allgrove, J., Arslan-Kirchner, M., Batch, J. A., Beighton, P., Black, G. C, Boles, R. G., Boon, L. M., Borrone, C, Brunner, H. G., Carle, G. F., Dallapiccola, B., De Paepe, A., Floege, B., Halfhide, M. L., Hall, B., Hennekam, R. C, Hirose, T., Jans, A., Juppner, H., Kim, C. A., Keppler-Noreuil, K., Kohlschuetter, A., La Combe, D., Lambert, M., Lemyre, E., Letteboer, T., Peltonen, L., Ramesar, R. S., Romanengo, M., Somer, H., Steichen-Gersdorf, E., Steinmann, B., Sullivan, B., Superti-Furga, A., Swoboda, W., Van Den Boogaard, M. J., Van Hul, W., Vikkula, M., Votruba, M., Zabel, B., Garcia, T., Baron, R., Olsen, B. R., Warman, M. L., and Osteoporosis-Pseudoglioma Syndrome Collaborative Group (2001) LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107, 513-523
15. Boyden, L. M., Mao, J., Belsky, J., Mitzner, L., Farhi, A., Mitnick, M. A., Wu, D., Insogna, K., and Lifton, R. P. (2002) High bone density due to a mutation in LDL-receptor-related protein 5. N. Engl. J. Med. 346, 1513-1521
16. Kokubu, C, Heinzmann, U., Kokubu, T., Sakai, N, Kubota, T., Kawai, M., Wahl, M. B., Galceran, J., Grosschedl, R., Ozono, K., and Imai, K. (2004) Skeletal defects in ringelschwanz mutant mice reveal that Lrp6 is required for proper somitogenesis and osteogenesis. Development 131, 5469-5480
17. Kato, M., Patel, M. S., Levasseur, R., Lobov, I., Chang, B. H., Glass, D. A., 2nd., Hartmann, C, Li, L., Hwang, T.-H., Brayton, C. F., Lang, R. A., Karsenty, G., and Chan, L. (2002) Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, aWnt coreceptor. J. Cell Biol. 157, 303-314
18. Morvan, F., Boulukos, K., Clément-Lacroix, P., Roman Roman, S., Suc-Royer, I., Vayssière, B., Ammann, P., Martin, P., Pinho, S., Pognonec, P., Mollat, P., Niehrs, C, Baron, R., and Rawadi, G. (2006) Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass. J. Bone Miner. Res. 21, 934-945
19. Akiyama, H, Kim, J. E., Nakashima, K., Balmes, G., Iwai, N, Deng, J. M., Zhang, Z., Martin, J. F., Behringer, R. R., Nakamura, T., and De Crombrugghe, B. (2005) Osteo-chondroprogenitor cells are derived from Sox9 expressing precursors. Proc. Natl. Acad. Sci. U. S. A. 102, 14665-14670
20. Glass, D. A., 2nd., Bialek, P., Ahn, J. D., Starbuck, M., Patel, M. S., Clevers, H, Taketo, M. M., Long, F., McMahon, A. P., Lang, R. A., and Karsenty, G. (2005) Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev. Cell 8, 751-764
21. Mak, K. K., Chen, M.-H., Day, T. F., Chuang, P.-T., and Yang, Y. (2006) Wnt/β-catenin signaling interacts differentially with Ihh signaling in controlling endochondral bone and synovial joint formation. Development 133, 3695-3707
22. Zhang, C, Cho, K., Huang, Y., Lyons, J. P., Zhou, X., Sinha, K., McCrea, P. D., and De Crombrugghe, B. (2008) Inhibition of Wnt signaling by the osteoblast-specific transcription factor Osterix. Proc. Natl. Acad. Sci. U. S. A. 105, 6936-6941
23. 2+ channel, hemichannel, and gap junction to promote osteoblast differentiation. J. Cell Biol. 193, 1257-1274
24. Baranova, A., Ivanov, D., Petrash, N, Pestova, A., Skoblov, M., Kelmanson, I., Shagin, D., Nazarenko, S., Geraymovych, E., Litvin, O., Tiunova, A., Born, T. L., Usman, N, Staroverov, D., Lukyanov, S., and Panchin, Y. (2004) The mammalian pannexin family is homologous to the invertebrate innexin gap junction proteins. Genomics. 83, 706-716
25. Bruzzone, R., Hormuzdi, S. G., Barbe, M. T., Herb, A., and Monyer, H. (2003) Pannexins, a family of gap junction proteins expressed in brain. Proc. Natl. Acad. Sci. U. S. A. 100, 13644-13649
26. Ray, A., Zoidl, G., Wahle, P., and Dermietzel, R. (2006) Pannexin expression in the cerebellum. Cerebellum 5, 189-192
27. Vogt, A., Hormuzdi, S. G., and Monyer, H. (2005) Pannexin1 and Pannexin2 expression in the developing and mature rat brain. Brain Res. Mol. Brain Res. 141, 113-120
28. Penuela, S., Bhalla, R., Gong, X. Q., Cowan, K. N, Celetti, S. J., Cowan, B. J., Bai, D., Shao, Q., and Laird, D. W. (2007) Pannexin 1 and pannexin 3 are glycoproteins that exhibit many distinct characteristics from the connexin family of gap junction proteins. J. Cell Sci. 120, 3772-3783
29. Lohman, A. W., Billaud, M., Straub, A. C, Johnstone, S. R., Best, A. K., Lee, M., Barr, K., Penuela, S., Laird, D. W., and Isakson, B. E. (2012) Expression of pannexin isoforms in the systemic murine arterial network. J. Vasc. Res. 49, 405-416
30. Iwamoto, T., Nakamura, T., Doyle, A., Ishikawa, M., De Vega, S., Fukumoto, S., and Yamada, Y. (2010) Pannexin 3 regulates intracellular ATP/cAMP levels and promotes chondrocyte differentiation. J. Biol. Chem. 285, 18948-18958
31. Matsunobu, T., Torigoe, K., Ishikawa, M., De Vega, S., Kulkarni, A. B., Iwamoto, Y., and Yamada, Y. (2009) Critical roles of the TGF-β type I receptor ALK5 in perichondrial formation and function, cartilage integrity, and osteoblast differentiation during growth plate development. Dev. Biol. 332, 325-338
32. Farr, A., and Roman, A. (1992) A pitfall of using a second plasmid to determine transfection efficiency. Nucleic Acids Res. 20, 920
33. Lustig, B., Jerchow, B., Sachs, M., Weiler, S., Pietsch, T., Karsten, U., Van De Wetering, M., Clevers, H., Schlag, P. M., Birchmeier, W., and Behrens, J. (2002) Negative feedback loop of Wnt signaling through upregulation of conductin/axin2 in colorectal and liver tumors. Mol. Cell Biol. 22, 1184-1193
34. Mohammad, K. S., Chirgwin, J. M., and Guise, T. A. (2008) Assessing new bone formation in neonatal calvarial organ cultures. Methods Mol. Biol. 455, 37-50
35. Wu, X., Downes, S., and Watts, D. C. (2010) Evaluation of critical size defects of mouse calvarial bone. An organ culture study. Microsc. Res. Tech. 73, 540-547
36. Bellows, C. G., and Heersche, J. N (2001) The frequency of common progenitors for adipocytes and osteoblasts and of committed and restricted adipocyte and osteoblast progenitors in fetal rat calvaria cell populations. J. Bone Miner. Res. 16, 1983-1993
37. Ecarot-Charrier, B., Glorieux, F. H, Van Der Rest, M., and Pereira, G. (1983) Osteoblasts isolated from mouse calvaria initiate matrix mineralization in culture. J. Cell Biol. 96, 639-643
38. Raucci, A., Bellosta, P., Grassi, R., Basilico, C, and Mansukhani, A. (2008) Osteoblast proliferation or differentiation is regulated by relative strengths of opposing signaling pathways. J. Cell Physiol. 215, 442-451
39. Haÿ, E., Nouraud, A., and Marie, P. J. (2009) N-cadherin negatively regulates osteoblast proliferation and survival by antagonizing Wnt, ERK and PI3K/Akt signalling. PLoS One 4, e8284
40. Kubota, T., Michigami, T., and Ozono, K. (2009) Wnt signaling in bone metabolism. J. Bone Miner. Metab. 27, 265-271
41. Urano, T. (2007) [Regulation of bone metabolism by pathogenic mutations and polymorphism in the LRP5-Wnt signaling genes]. Nihon Rinsho 65, (Suppl. 9) 95-100
42. Bernardi, H., Gay, S., Fedon, Y., Vernus, B., Bonnieu, A., and Bacou, F. (2011) Wnt4 activates the canonical β-catenin pathway and regulates negatively myostatin. Functional implication in myogenesis. Am. J. Physiol. Cell Physiol. 300, C1122-C1138
43. Nakashima, A., Katagiri, T., and Tamura, M. (2005) Cross-talk between Wnt and bone morphogenetic protein 2 (BMP-2) signaling in differentiation pathway of C2C12 myoblasts. J. Biol. Chem. 280, 37660-37668
44. Van Amerongen, R., and Nusse, R. (2009) Towards an integrated view of Wnt signaling in development. Development 136, 3205-3214
45. Westendorf, J. J., Kahler, R. A., and Schroeder, T. M. (2004) Wnt signaling in osteoblasts and bone diseases. Gene 341, 19-39
46. Cooper, D. M. (2003) Regulation and organization of adenylyl cyclases and cAMP. Biochem. J. 375, 517-529
47. Ryten, M., Dunn, P. M., Neary, J. T., and Burnstock, G. (2002) ATP regulates the differentiation of mammalian skeletal muscle by activation of a P2X5 receptor on satellite cells. J. Cell Biol. 158, 345-355
48. Dumont, J. E., Jauniaux, J. C, and Roger, P. P. (1989) The cyclic AMP-mediated stimulation of cell proliferation. Trends Biochem. Sci. 14, 67-71
49. Beier, F., and Lu Valle, P. (2002) The cyclin D1 and cyclin A genes are targets of activated PTH/PTHrP receptors in Jansen's metaphyseal chondrodysplasia. Mol. Endocrinol. 16, 2163-2173
50. Wang, A., Schneider-Broussard, R., Kumar, A. P., MacLeod, M. C, and Johnson, D. G. (2000) Regulation of BRCA1 expression by the Rb-E2F pathway. J. Biol. Chem. 275, 4532-4536
51. Bellosta, P., Masramon, L., Mansukhani, A., and Basilico, C. (2003) p21 (WAF1/CIP1) acts as a brake in osteoblast differentiation. J. Bone Miner. Res. 18, 818-826
52. Pardali, K., Kowanetz, M., Heldin, C.-H, and Moustakas, A. (2005) Smad pathway-specific transcriptional regulation of the cell cycle inhibitor p21 (WAF1/Cip1). J. Cell Physiol. 204, 260-272
53. Almeida, M., Han, L., Bellido, T., Manolagas, S. C, and Kousteni, S. (2005) Wnt proteins prevent apoptosis of both uncommitted osteoblast progenitors and differentiated osteoblasts by β-catenin-dependent and -independent signaling cascades involving Src/ERK and phosphatidylinositol 3-kinase/AKT. J. Biol. Chem. 280, 41342-41351
54. Zhang, L., Shi, S., Zhang, J., Zhou, F., and Ten Dijke, P. (2012) Wnt/β-catenin signaling changes C2C12 myoblast proliferation and differentiation by inducing Id3 expression. Biochem. Biophys. Res. Commun. 419, 83-88
55. Rawadi, G., Vayssière, B., Dunn, F., Baron, R., and Roman-Roman, S. (2003) BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by aWnt autocrine loop. J. Bone Miner. Res. 18, 1842-1853
56. Huelsken, J., and Birchmeier, W. (2001) New aspects of Wnt signaling pathways in higher vertebrates. Curr. Opin. Genet. Dev. 11, 547-553
57. Komori, T., Yagi, H., Nomura, S., Yamaguchi, A., Sasaki, K., Deguchi, K., Shimizu, Y., Bronson, R. T., Gao, Y. H., Inada, M., Sato, M., Okamoto, R., Kitamura, Y., Yoshiki, S., and Kishimoto, T. (1997) Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89, 755-764
58. Otto, F., Thornell, A. P., Crompton, T., Denzel, A., Gilmour, K. C., Rosewell, I. R., Stamp, G. W., Beddington, R. S., Mundlos, S., Olsen, B. R., Selby, P. B., and Owen, M. J. (1997) Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89, 765-771
59. Berridge, M. J., Lipp, P., and Bootman, M. D. (2000) The versatility and universality of calcium signalling. Nat. Rev. Mol. Cell Biol. 1, 11-21
60. Seo, J. H., Jin, Y.-H., Jeong, H. M., Kim, Y.-J., Jeong, H. G., Yeo, C.-Y., and Lee, K.-Y. (2009) Calmodulin-dependent kinase II regulates Dlx5 during osteoblast differentiation. Biochem. Biophys. Res. Commun. 384, 100-104
61. Sun, L., Blair, H. C., Peng, Y., Zaidi, N, Adebanjo, O. A., Wu, X. B., Wu, X. Y., Iqbal, J., Epstein, S., Abe, E., Moonga, B. S., and Zaidi, M. (2005) Calcineurin regulates bone formation by the osteoblast. Proc. Natl. Acad. Sci. U. S. A. 102, 17130-17135
62. Zayzafoon, M. (2006) Calcium/calmodulin signaling controls osteoblast growth and differentiation. J. Cell Biochem. 97, 56-70
63. 2+ channel. From discovery to new signaling concepts. J. Neurochem. 102, 1426-1446
64. Futatsugi, A., Nakamura, T., Yamada, M. K., Ebisui, E., Nakamura, K., Uchida, K., Kitaguchi, T., Takahashi-Iwanaga, H., Noda, T., Aruga, J., and Mikoshiba, K. (2005) IP3 receptor types 2 and 3 mediate exocrine secretion underlying energy metabolism. Science 309, 2232-2234